The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durvalumab Effective in Advanced Disease?

165 views
September 9, 2020
Comments 0
Login to view comments. Click here to Login